Brenus Pharma secures an €11 million Series A extension, led by new European and Asia-Pacific life sciences investors, to enhance its proprietary platform and support clinical-stage developments.
Amount Raised
€11 Million
Round Type
Series A
Description
Brenus Pharma announced an €11 million ($12.6M) extension to its Series A round, bringing total capital raised since inception to €38 million ($43.5M). This funding reflects strong execution across clinical and regulatory milestones. The company aims to de-risk its lead clinical-stage immunotherapy, STC-1010, while expanding its proprietary platform. New investments come from notable European and Asia-Pacific life sciences investors.
Quick answer
Brenus Pharma raised €11 Million in a Series A round, dated July 20, 2026. Brenus Pharma is based in Lyon, Auvergne Rhône Alpes, France.
- How much did Brenus Pharma raise?
- Brenus Pharma raised €11 Million in a Series A round on July 20, 2026.
- What does Brenus Pharma do?
- Brenus Pharma is a biotech company that specializes in the development of precision cancer vaccines.
- Where is Brenus Pharma based and how big is it?
- Brenus Pharma is based in Lyon, Auvergne Rhône Alpes, France. Fundz records about 28 employees.
- Who are the decision-makers at Brenus Pharma?
- Fundz holds 2 contacts at Brenus Pharma. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who to call at Brenus Pharma, and when
A new round usually means Brenus Pharma is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Brenus Pharma raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Brenus Pharma, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Brenus Pharma. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Brenus Pharma raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansBrenus Pharma raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.